Pharmaceutical Supply chains are no longer linear—they're dynamic ecosystems vulnerable to disruption yet ripe for reinvention. This panel examines U.S.-specific, but globally influenced supply chain risks and how AI, automation, and emerging technologies are redefining resilience. We'll uncover how predictive intelligence, real-time visibility, and digital twins can transform fragility into strength, enabling organizations to anticipate shocks and respond with speed. Join us to explore the future of supply chains—where risk management and digital transformation converge to create smarter, more agile networks.
